Avtor/Urednik		Čufer, T; Vrhovec, I; Borštnar, S
Naslov		Prognostic significance of plasminogen activator inhibitor-1 in breast cancer, with special emphasis on locoregional recurrence-free survival
Tip		članek
Vir		Int J Biol Markers
Vol. in št.		Letnik 17, št. 1
Leto izdaje		2002
Obseg		str. 33-41
Jezik		eng
Abstrakt		The independent prognostic value of protease uPA and its inhibitor PAI-1 for survival in breast cancer patients is firmly established. However, there is very little data on the prognostic value of serine proteases and their inhibitors for locoregional recurrence in breast cancer. The prognostic value of PAI-1 for local control in a group of 766 patients treated at our institute with either breast conserving treatment or modified radical mastectomy was evaluated. The locoregional recurrence-free survival (LRFS) of patients with PAI-1 values above the median value was significantly worse than that of patients with PAI-1 values below the median value (log-rank; p=0.0078). In multivariate analysis PAI-1 levels proved to be of independent statistical significance for LRFS (p=0.0401, relative risk 2.28, 95% confidence interval 1.04-5.02). The independent prognostic value of PAI-1 for metastasis-free survival and overall survival was also confirmed. In addition, our data suggest that PAI-1 antigen levels in tumor tissue might be of prognostic value for survival after locoregional recurrence (log-rank; p=0.0618). According to our findings, PAI-1 levels could be used as a biological marker that could facilitate the identifation of patients with a higher risk of local relapse already at the time of primary treatment. These patients should then be offered more aggressive treatment.
Deskriptorji		BREAST NEOPLASMS PLASMINOGEN ACTIVATOR INHIBITOR 1 DISEASE-FREE SURVIVAL NEOPLASM METASTASIS NEOPLASM STAGING SURVIVAL ANALYSIS FOLLOW-UP STUDIES PROGNOSIS